Title : Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Pub. Date : 2022

PMID : 35280867






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tofogliflozin and pioglitazone induced a significantly higher decrease in the K-18 level than a placebo. 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol keratin 18 Homo sapiens
2 Tofogliflozin and pioglitazone induced a significantly higher decrease in the K-18 level than dulaglutide. 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol keratin 18 Homo sapiens
3 Tofogliflozin treatment had the highest SUCRA ranking in decreasing K-18, while dapagliflozin treatment had the highest SUCRA ranking in decreasing the GGT level. 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol keratin 18 Homo sapiens